Company: AGIO
Filing Date: 2025-04-25
Form Type: DEF 14A
Source: 0001193125-25-096719
Chunk: 38

Company: AGIOS PHARMACEUTICALS, INC.
Filing Date: 2025-04-25
Form: DEF 14A
Chunk 38
---
 day-to-daybusiness, while allowing the chair of the board to lead the board of directors in its fundamental role of providing advice to and independent oversight of management. Specifically, the chair of our board of directors presides over meetings of the board of directors, facilitates communications between management and the board of directors, provides input on the design of the board of directors and assists with other corporate governance matters. Because Dr. Fouse, the chair of our board of directors, is not independent within the meaning of the Nasdaq Listing Rules, our board of directors, upon the recommendation of our nominating and corporate governance committee, has appointed Ms. Foster as lead independent director. Ms. Foster is an independent director within the meaning of the Nasdaq Listing Rules (see “Director Determination of Independence” above). Her duties as lead independent director include the following:

| • |     | Chairing meetings of the independent directors in executive session; |

25

| • |     | Meeting with any director who is not adequately performing his or her duties as a member of our board of directors or any committee; |

| • |     | Facilitating communications between other members of our board of directors, our chair and our chief executive officer; |

| • |     | Working with our chair and our chief executive officer in the preparation of the agenda for each board meeting and in determining the need for special meetings of our board of directors; |

| • |     | Monitoring, with the assistance of our chief legal officer, or his designee, communications from stockholders and other interested parties and providing copies or summaries to the other directors as she considers appropriate (see “Communications with our Board of Directors” below); and |

| • |     | Consulting with our chair and our chief executive officer on matters relating to corporate governance and board performance. |

Our nominating and corporate governance committee evaluates our board leadership structure from time to time and may recommend further alterations of this structure in the future. Director Nomination Process Director Qualifications In evaluating director nominees, the nominating and corporate governance committee will consider, among other things, the following factors:

| • |     | reputation for personal and professional integrity, honesty and adherence to high ethical standards; |

| • |     | demonstrated business acumen, experience and ability to exercise sound judgments in matters that relate to the current and long-term objectives of our company and should be willing and able to contribute positively to the decision-making process of our company; |

| • |     | strong finance experience; |

| • |     | commitment